Yıldız Pehlivan, Deniz, Hamit Yıldız, and Gökhan Kaya. 2025. “Dapagliflozin Modulates MicroRNA Expression in Type 2 Diabetes Patients With Diabetic Nephropathy: A Retrospective Study”. European Journal of Therapeutics 31 (1):1-10. https://doi.org/10.58600/eurjther2520.